ANDROGENETIC ALOPECIA (AGA)
Clinical trials for ANDROGENETIC ALOPECIA (AGA) explained in plain language.
Never miss a new study
Get alerted when new ANDROGENETIC ALOPECIA (AGA) trials appear
Sign up with your email to follow new studies for ANDROGENETIC ALOPECIA (AGA), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New pill could regrow hair in balding men
Disease control Not yet recruitingThis study tests whether a daily oral minoxidil pill (N1087) can help regrow hair in men with male pattern baldness. About 372 men aged 18 to 60 with moderate hair loss will take either the drug or a placebo for 24 weeks, with the dose slowly increased. The main goal is to see if…
Matched conditions: ANDROGENETIC ALOPECIA (AGA)
Phase: PHASE3 • Sponsor: Eurofarma Laboratorios S.A. • Aim: Disease control
Last updated Jun 27, 2026 12:08 UTC
-
New DA-001 hair loss treatment heads to Large-Scale trial
Disease control Not yet recruitingThis study tests whether a treatment called DA-001 can safely reduce hair shedding and promote regrowth in people with certain types of hair loss, including telogen effluvium and female or male pattern baldness. About 1,120 adults will apply the treatment as directed and be monit…
Matched conditions: ANDROGENETIC ALOPECIA (AGA)
Phase: PHASE2, PHASE3 • Sponsor: Applied Biology, Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:06 UTC
-
One shot to stop balding? new trial tests fat injections against daily cream
Disease control Not yet recruitingThis study tests whether a single injection of nanofat (processed fat from your own body) can treat pattern hair loss better than standard options. Sixty adults with androgenetic alopecia will receive either one nanofat injection, three monthly PRP injections, or daily topical mi…
Matched conditions: ANDROGENETIC ALOPECIA (AGA)
Phase: PHASE4 • Sponsor: Assiut University • Aim: Disease control
Last updated Jun 27, 2026 12:06 UTC